Seminars in Radiation Oncology
Volume 19, Issue 1 , Pages 3-10, January 2009

Current State-of-the-Art for Concurrent Chemoradiation

  • Jacques Bernier, MD, PD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Jacques Bernier, MD, PD, Department of Radiation Oncology, Genolier Swiss Medical Network, Clinique de Genolier, 4, route du Muids, CH −1272 Genolier Switzerland

Department of Radiation Oncology; Genolier Swiss Medical Network, Genolier, Switzerland

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 J. Bernier is occasionally member of advisory boards for Amgen, GlaxoSmithKline, Merck-Serono, and Sanofi-Aventis.

PII: S1053-4296(08)00057-X

doi:10.1016/j.semradonc.2008.09.002

Seminars in Radiation Oncology
Volume 19, Issue 1 , Pages 3-10, January 2009

Article Tools

* Image Usage & Resolution